Healthcare -
Biotechnology - NASDAQ - US
$ 6.74
2.43 %
$ 686 M
Market Cap
-14.98
P/E
TRVI - TOTAL OTHER INCOME
Total Other Income TRVI - Trevi Therapeutics, Inc.
3.58 M
LAST VALUE
123.23%
2 YEAR CAGR
44.08%
5 YEAR CAGR
0.00%
10 YEAR CAGR